ARIAD To Present at The 33rd Annual J.P. Morgan Healthcare Conference
December 22 2014 - 7:35AM
Business Wire
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that
it will present at the 33rd Annual J.P. Morgan Healthcare
Conference being held in San Francisco. Harvey J. Berger, M.D.,
chairman and chief executive officer, will provide an overview of
the Company’s business on Wednesday, January 14 at 3:00 p.m.
(PT).
The ARIAD presentation at the J.P. Morgan Healthcare Conference
will be webcast live and can be accessed by visiting the investor
relations section of the Company's website at
http://www.ariad.com/investor. A replay of the presentation will
also be available and archived on the site for three weeks.
About ARIAD
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge,
Massachusetts and Lausanne, Switzerland, is an integrated global
oncology company focused on transforming the lives of cancer
patients with breakthrough medicines. ARIAD is working on new
medicines to advance the treatment of various forms of chronic and
acute leukemia, lung cancer and other difficult-to-treat cancers.
ARIAD utilizes computational and structural approaches to design
small-molecule drugs that overcome resistance to existing cancer
medicines. For additional information, visit
http://www.ariad.com or follow ARIAD on Twitter
(@ARIADPharm).
ARIAD Pharmaceuticals, Inc.For InvestorsKendra Adams,
617-503-7028Kendra.adams@ariad.comorFor MediaLiza Heapes,
617-621-2315Liza.heapes@ariad.com
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Apr 2023 to Apr 2024